Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies: a case report.

Literature DB >> 30635801

Cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies: a case report.

Silvia Maria Villa¹, Alessandra Rufa², Alessandro Malandrini², Alfonso Cerase³, Francesca Rosini², Umberto Arrigucci³, Antonio Federico².

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2019 PMID： 30635801 DOI： 10.1007/s10072-019-3701-6

Source DB: PubMed Journal: Neurol Sci ISSN： 1590-1874 Impact factor: 3.830

× No keyword cloud information.

6 in total

1. GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders.

Authors: A Boronat; L Sabater; A Saiz; J Dalmau; F Graus
Journal: Neurology Date: 2011-03-01 Impact factor: 9.910

Review 2. Cerebellar disease associated with anti-glutamic acid decarboxylase antibodies: review.

Authors: José Fidel Baizabal-Carvallo; Marlene Alonso-Juarez
Journal: J Neural Transm (Vienna) Date: 2017-07-08 Impact factor: 3.575

3. GABA-A receptor impairment in cerebellar ataxia with anti-glutamic acid decarboxylase antibodies.

Authors: Yasushi Hosoi; Makiko Suzuki-Sakao; Tatsuhiro Terada; Takashi Konishi; Yasuomi Ouchi; Hiroaki Miyajima; Satoshi Kono
Journal: J Neurol Date: 2013-10-05 Impact factor: 4.849

4. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.

Authors: Albert Saiz; Yolanda Blanco; Lidia Sabater; Félix González; Luis Bataller; Roser Casamitjana; Lluis Ramió-Torrentà; Francesc Graus
Journal: Brain Date: 2008-08-07 Impact factor: 13.501

5. Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults.

Authors: Amy L Jones; Eoin P Flanagan; Sean J Pittock; Jay N Mandrekar; Scott D Eggers; J Eric Ahlskog; Andrew McKeon
Journal: JAMA Neurol Date: 2015-11 Impact factor: 18.302

6. Anti-GAD Antibodies and the Cerebellum: Where Do We Stand?

Authors: Mario Manto; Hiroshi Mitoma; Christiane S Hampe
Journal: Cerebellum Date: 2019-04 Impact factor: 3.847

6 in total

4 in total

Cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies: a case report.

1. GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders.

Review 2. Cerebellar disease associated with anti-glutamic acid decarboxylase antibodies: review.

3. GABA-A receptor impairment in cerebellar ataxia with anti-glutamic acid decarboxylase antibodies.

4. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.

5. Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults.

6. Anti-GAD Antibodies and the Cerebellum: Where Do We Stand?

1. Rare Neurologic Diseases and Neurological Sciences: a report for the celebration of the 2020 Rare Diseases Day.

2. Anti-GAD epileptic encephalopathy in a toddler with Parry-Romberg syndrome.

3. Are anti-glutamic acid decarboxylase 65-kDa isoform antibodies related to diabetes or brain tumor?

4. Cerebellar glutamatergic system impacts spontaneous motor recovery by regulating Gria1 expression.